Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer’s disease in the APP23 mouse model-Reference-Cited by-同舟云学术

Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer’s disease in the APP23 mouse model

Published:2018-07 Issue: Volume:347 Page:300-313
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Pfeffer Anna,Munder Tonia,Schreyer Stefanie,Klein Charlotte,Rasińska Justyna,Winter York,Steiner Barbara

Funder

Deutsche Forschungsgemeinschaft

Sonnenfeld Stiftung and Charité – Universitätsmedizin Berlin

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference102 articles.

1. Alzheimer’s disease facts and figures;Alzheimer’s, A;Alzheimers Dement,2016

2. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers;Reitz;Biochem. Pharmacol.,2014

3. Current and future treatments for Alzheimer’s disease;Yiannopoulou;Ther. Adv. Neurol. Disord.,2013

4. 100 years and counting: prospects for defeating Alzheimer's disease;Roberson;Science,2006

5. Multimodal techniques for diagnosis and prognosis of Alzheimer’s disease;Perrin;Nature,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Environmental enrichment improves cognitive function, learning, memory and anxiety-related behaviours in rodent models of dementia: Implications for future study;Neurobiology of Learning and Memory;2024-02

3. Apathy-like behaviour in tau mouse models of Alzheimer’s disease and frontotemporal dementia;Behavioural Brain Research;2024-01

4. Reduction of restricted repetitive behavior by environmental enrichment: Potential neurobiological mechanisms;Neuroscience & Biobehavioral Reviews;2023-09

5. Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation;Neuropharmacology;2022-05